How long before hydroxychloroquine works?

Most patients notice some improvement at 1-3 months, but full therapeutic benefit requires 3-6 months of consistent daily use. If after 6 months there is no improvement, your rheumatologist will reassess the treatment plan. This is a slow-acting medication — patience is essential.

What is the retinal toxicity risk and how is it monitored?

Hydroxychloroquine can deposit in the retina with long-term use, causing irreversible damage to central vision (Bull's eye maculopathy). Risk is low with correct weight-based dosing and low during the first 5 years of use. An ophthalmologic baseline exam is required at or before starting, with annual screening beginning at 5 years (or sooner in high-risk patients: kidney disease, age over 60, high dose, pre-existing retinal disease). Automated visual field testing and spectral-domain OCT are the preferred screening modalities.

Can I take hydroxychloroquine while pregnant?

Yes. Hydroxychloroquine is considered one of the safer medications for lupus in pregnancy. For SLE patients, continuing hydroxychloroquine during pregnancy is generally recommended, as stopping is associated with increased flare risk. It crosses the placenta at low levels but is not teratogenic.

Is hydroxychloroquine the same as chloroquine?

Hydroxychloroquine and chloroquine are closely related antimalarial drugs, but hydroxychloroquine has a better safety profile (particularly lower risk of retinal toxicity) and has largely replaced chloroquine for long-term autoimmune disease treatment. They are not interchangeable without dose adjustment.

What to Expect When Starting Hydroxychloroquine

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting, stopping, or changing any medication. Using this site does not create a doctor-patient relationship.

Drug information changes as the FDA updates labeling, and we cannot guarantee it is complete or current. Verify critical details with your pharmacist or physician.

Emergencies: If you think you may have a medical emergency, call 911 immediately. For a suspected overdose, call Poison Control at 1-800-222-1222. Report side effects to the FDA MedWatch program at fda.gov/medwatch or 1-800-FDA-1088.

See our Terms of Use and Editorial Policy.

Introduction

Hydroxychloroquine (Plaquenil) is an antimalarial drug with significant immunomodulatory properties, used to treat lupus (SLE), rheumatoid arthritis, Sjogren syndrome, and other inflammatory conditions. It is one of the safest long-term treatments for autoimmune disease, but it takes months to reach full therapeutic effect. Regular ophthalmologic monitoring is required due to the risk of irreversible retinal damage with long-term use.

Week-by-week timeline

Week 1-2

Starting and Tolerability

Hydroxychloroquine is typically started at 200-400 mg/day, with dosing based on body weight (maximum 5 mg/kg/day). Common early side effects include nausea, diarrhea, and stomach upset — take with food. Skin sensitivity to sunlight increases. Headache and dizziness may occur initially.

Week 2-8

Adjustment Period

GI side effects typically improve over the first 4-6 weeks. Some patients notice early improvement in joint symptoms or skin rash (for lupus), but full anti-inflammatory effects take months to develop.

Month 1-3

Early Therapeutic Effects

Some improvement in lupus symptoms (fatigue, joint pain, skin rash, low-grade fever) may begin at 1-3 months. Rheumatoid arthritis patients may notice improved morning stiffness and reduced inflammation. Labs (inflammatory markers, blood counts) may begin to normalize.

Month 3-6

Building to Full Effect

Full anti-inflammatory and immunomodulatory effects of hydroxychloroquine typically require 3-6 months of consistent therapy. Disease activity scores should be measurably lower. Do not give up before 6 months.

Month 6+

Long-Term Disease Management

Hydroxychloroquine reduces lupus flares, reduces damage accrual over years, lowers mortality in SLE, and reduces risk of thrombosis. In RA, it reduces inflammation and may slow disease progression. Annual ophthalmologic exams are required for retinal monitoring beginning at 5 years of use (earlier in high-risk patients).

When to call your doctor

Contact your healthcare provider if you experience:

Any visual changes: blurred vision, difficulty reading, seeing halos, loss of central vision, or color vision changes (possible retinal toxicity — stop and seek ophthalmologic evaluation immediately)
Severe rash with blistering or peeling (Stevens-Johnson syndrome — rare but serious)
Signs of serious blood disorder: unusual bruising, pallor, severe infections (bone marrow suppression — rare)
Irregular heartbeat or palpitations (QT prolongation — particularly with other QT-prolonging drugs)
Severe muscle weakness (myopathy — rare)
Worsening of psoriasis (hydroxychloroquine can precipitate or worsen psoriasis)
Signs of liver toxicity: yellowing of skin or eyes, dark urine

Tips for getting started

Take hydroxychloroquine with food to significantly reduce GI side effects. Use broad-spectrum sunscreen and protective clothing — photosensitivity is increased. Never miss the baseline ophthalmologic exam before or at the start of treatment, and annual exams from year 5 onward (earlier if risk factors). If you notice any visual symptoms, stop the medication and see an ophthalmologist urgently — retinal damage is irreversible. Do not stop without consulting your rheumatologist — the disease benefit is maintained only with continuous therapy. Hydroxychloroquine is generally safe in pregnancy and is continued for most pregnant patients with lupus.

Frequently asked questions

More about Hydroxychloroquine

Hydroxychloroquine drug guideSide effects, dosage, interactions, and more Methotrexate vs HydroxychloroquineCompare these medications Hydroxychloroquine & AzithromycinInteraction details

References

[Regulatory] FDA Label: Plaquenil (hydroxychloroquine sulfate) Tablets https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/009768s037s045lbl.pdf Accessed 2026-03-01.
[Regulatory] NIH MedlinePlus: Hydroxychloroquine https://medlineplus.gov/druginfo/meds/a601240.html Accessed 2026-03-01.
[Regulatory] ACR Hydroxychloroquine Retinopathy Screening Guidelines 2016 https://onlinelibrary.wiley.com/doi/10.1002/art.39683 Accessed 2026-03-01.

Written and fact-checked by PrescriptionDrugs.org Editorial Team

Last updated: March 1, 2026